# Biomarkers of balance and gait deficits in FMR1 premutation carriers: a mini-review

**Authors:** Leila C. Moore, Nell Maltman, Jonathan S. Lee-Confer, Megan J. Kobel

PMC · DOI: 10.3389/fnagi.2025.1637819 · Frontiers in Aging Neuroscience · 2025-10-06

## TL;DR

This mini-review explores how balance and gait issues in people with a specific genetic mutation may help detect early signs of a neurodegenerative disorder.

## Contribution

The paper synthesizes current findings on digital biomarkers of gait and balance in FMR1 premutation carriers for early detection of FXTAS.

## Key findings

- Variability measures of gait and postural sway show impairments in individuals with FXTAS.
- There is limited data on gait and balance in FMR1 PM carriers without FXTAS.
- Future studies should track gait and balance longitudinally in PM carriers.

## Abstract

Fragile X-associated tremor/ataxia syndrome (FXTAS) is a neurodegenerative disorder caused by a premutation (PM) of the FMR1 gene on the X chromosome. FXTAS is characterized by intention tremor, ataxia, and cognitive decline. Age-related cognitive-behavioral and sensorimotor (i.e., balance and gait) abnormalities are also present in PM carriers who do not develop FXTAS. Digital biomarkers of gait and balance have been proposed to be promising markers in characterizing prodromal changes in FXTAS (i.e., preFXTAS) and identifying age-related changes in the FMR1 phenotype in those who do not develop FXTAS. In this mini-review, gait and balance findings in PM carriers are reviewed to highlight potential future applications. Variability measures of gait and postural sway reveal measurable impairments in individuals with FXTAS, particularly under conditions challenging sensory integration or assessing cognitive-motor interactions. However, there are limited studies quantifying these domains in FMR1 PM carriers without FXTAS, and there is significant variability in the patient populations assessed (i.e., differing ages, relative lack of information in females) thus restricting conclusions about the progression of balance and gait in FXTAS and possible prodromal markers. Future research should prioritize longitudinal tracking of gait and balance in PM carriers, along with potential cognitive interactions and the characterization of sensory contributions to postural control. This mini-review aims to synthesize current findings on digital balance and gait biomarkers in FMR1 premutation carriers and to explore their potential utility for early FXTAS detection.

## Linked entities

- **Genes:** FMR1 (fragile X messenger ribonucleoprotein 1) [NCBI Gene 2332]
- **Diseases:** FXTAS (MONDO:0010382)

## Full-text entities

- **Genes:** FMR1 (fragile X messenger ribonucleoprotein 1) [NCBI Gene 2332] {aka FMRP, FRAXA, POF, POF1}
- **Diseases:** FXTAS (MESH:C564105), ataxia (MESH:D001259), tremor (MESH:D014202), and gait deficits (MESH:D020233), cognitive decline (MESH:D003072), neurodegenerative disorder (MESH:D019636)
- **Species:** Homo sapiens (human, species) [taxon 9606]

## Full text

_Full body text omitted from this summary view._ Fetch the complete paper as Markdown: https://tomesphere.com/paper/PMC12535985/full.md

## References

73 references — full list in the complete paper: https://tomesphere.com/paper/PMC12535985/full.md

---
Source: https://tomesphere.com/paper/PMC12535985